Photo detail

Stories this photo appears in:

Lumena Pharmaceuticals Closes $45M Funding Round

Lumena Pharmaceuticals Inc. has closed a $45 million Series B round, and will use the funding to develop drugs for two diseases of the liver.

Tease photo

Lumena Drug Receives Positive Opinion for Orphan Drug Designation in EU

San Diego-based Lumena Pharmaceuticals Inc. announced its drug LUM001 has received a positive opinion for orphan drug designation from a European regulatory committee.

Tease photo